Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 15, 2026

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
13:35

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

Prophylactic mastectomy: an appraisal.

Flora Zagouri1, Dimosthenis T Chrysikos, Theodoros N Sergentanis

  • 1Breast Unit, 1st Department of Propaedeutic Surgery, Hippokratio Hospital, University of Athens, Athens, Greece. florazagouri@yahoo.co.uk

The American Surgeon
|January 23, 2013
PubMed
Summary

Prophylactic mastectomy is a key option for BRCA1/BREC2 mutation carriers. This review covers patient selection, effectiveness, limitations, guidelines, and future directions for this preventative surgery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"TROP-2 as a Therapeutic Target in NSCLC: The Promise of Sacituzumab Tirumotecan".

Critical reviews in oncology/hematology·2026
Same author

Epidemiological trends of non-small cell lung cancer and systemic treatment rates as part of initial therapeutic strategy from 2016 to 2020 in Greece: results of the epidemiological part of INFINITY study.

BMC cancer·2026
Same author

Sacituzumab Tirumotecan Across Gynecologic Malignancies: One Target, Multiple Diseases.

Current oncology reports·2026
Same author

CAFs and Endocrine Therapy Resistance in Hormone Receptor-Positive Breast Cancer.

International journal of molecular sciences·2026
Same author

Fulzerasib plus cetuximab in first-line KRAS<sup>G12C</sup>-mutated non-small-cell lung cancer (KROCUS): a single-arm, multicentre, phase 1b/2 trial.

The Lancet. Oncology·2026
Same author

Molecular Profiling and Treatment Outcomes in Uterine Serous Carcinoma: Prognostic Role of Estrogen Receptor Expression.

Current oncology (Toronto, Ont.)·2026

Area of Science:

  • Oncology
  • Surgical Oncology
  • Genetics

Background:

  • BRCA1 and BRCA2 gene mutations significantly increase breast cancer risk.
  • Prophylactic mastectomy is a risk-reducing surgical intervention.
  • Surgical options include simple and subcutaneous mastectomy, with potential for immediate or delayed breast reconstruction.

Purpose of the Study:

  • To review the critical aspects of prophylactic mastectomy.
  • To analyze patient selection criteria for this procedure.
  • To evaluate the effectiveness and limitations of prophylactic mastectomy.

Main Methods:

  • Literature review of prophylactic mastectomy.
  • Analysis of patient selection strategies.
  • Examination of surgical techniques and outcomes.

More Related Videos

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

Related Experiment Videos

Last Updated: May 15, 2026

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
13:35

Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction

Published on: May 17, 2024

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

  • Review of current clinical guidelines and future research.

    • Main Results:

    • Prophylactic mastectomy is primarily indicated for BRCA1/BRCA2 mutation carriers.
    • Effectiveness is high in risk reduction, but limitations exist.
    • Guidelines show some convergence and divergence regarding its application.
    • Breast reconstruction is an integral part of the process.

    Conclusions:

    • Prophylactic mastectomy is a vital strategy for high-risk individuals.
    • Careful patient selection and understanding of limitations are crucial.
    • Further research and guideline harmonization are needed for optimal patient care.